ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946 to 1948

Total Page:16

File Type:pdf, Size:1020Kb

ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946 to 1948 “ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946 to 1948 September 2011 ABOUT THE COVER: Detail taken from historical map Complete map shown above Author: Schrader; Vivien St Martin, L. Date: 1937 Short Title: Mexique Publisher: Librairie Hachette, Paris Type: Atlas Map Images copyright © 2000 by Cartography Associates David Rumsey Historical Map Collection www.davidrumsey.com “ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946 to 1948 Presidential Commission for the Study of Bioethical Issues Washington, D.C. September 2011 www.bioethics.gov “ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946-1948 ABOUT THE PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES The Presidential Commission for the Study of Bioethical Issues (the Commission) is an advisory panel of the nation’s leaders in medicine, science, ethics, religion, law, and engineering. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. For more information about the Commission, please see www.bioethics.gov. ii CONTENTS PREFACE ........................................................................................................ 1 BACKGROUND .............................................................................................. 9 Terre Haute Prison Experiments, 1943-1944 ................................................ 13 Implementing the Experiments .................................................................. 20 Developments in the Science and Prevention of Sexually Transmitted Diseases ... 23 GUATEMALA EXPERIMENTS 1946-1948 .................................................... 27 Initial Experiment Design ........................................................................... 28 Treatment Programs and Goodwill Efforts ................................................... 32 Serological Experiments .............................................................................. 36 Penitentiary ............................................................................................ 37 Children ................................................................................................. 38 Leprosarium ............................................................................................ 40 Psychiatric Hospital ................................................................................. 41 Intentional Exposure Experiments ............................................................... 41 Overview ................................................................................................ 41 Gonorrhea Experiments ............................................................................ 43 Syphilis Experiments ................................................................................ 52 Chancroid Experiments ............................................................................ 69 Winding Down the Guatemala Experiments ................................................ 70 Extension of the Grant ............................................................................ 70 Disposition of the Laboratory .................................................................... 71 Race and Secrecy during the Guatemala Experiments ................................... 72 Issues of Race ........................................................................................... 72 Concerns about Secrecy ............................................................................. 74 THE POST-CUTLER CONTINUATION OF THE GUATEMALA EXPERIMENTS AND FINAL REPORTS 1948-1955 ....................................... 81 Serology Experiments .................................................................................. 82 Continuing Observations ............................................................................ 83 PUBLICATION OF THE GUATEMALA DATA ............................................. 85 AFTERWORD ............................................................................................... 87 REVIEWING ETHICAL STANDARDS IN CONTEXT ................................. 91 Current Human Research Protections and Ethical Requirements of Our Own Time .......................................................................................................... 92 Longstanding Ethical Principles .................................................................. 93 Contemporaneous Standards for Ethical Research in 1946-1948 .................. 97 Evaluating General Mitigating Arguments ..................................................101 Evaluating Historically Specific Mitigating Arguments ............................... 104 iii “ETHICALLY IMPOSSIBLE” STD Research in Guatemala from 1946-1948 The Guatemala Experiments—Looking Back, Looking Ahead, and Apportioning Blame ..................................................................................107 TABLES AND FIGURES ..............................................................................109 Table 1: The Cutler Documents .................................................................. 110 Table 2: Individuals Involved in the STD Experiments in Guatemala ...........112 Table 3: Timeline of all Guatemala Experiments ......................................... 116 Table 4: Subject and Population Specific Data ............................................. 118 Figure 1: Organizational Chart of the Office of Scientific Research and Development ............................................................................................ 120 Figure 2. Organizational Chart of the National Research Council ...............121 Figure 3. Organizational Chart for the U.S. Public Health Service, 1946 ....... 122 Figure 4. Organizational Chart for the National Advisory Health Council, December 1946 ........................................................................................ 123 Figure 5. Organizational Chart for the Syphilis Study Section .................... 124 Figure 6: Intentional Exposure Experiments Goals over Time ......................125 Figure 7: Intentional Exposure Experiments over Time ............................... 126 Figure 8: Methods of Exposure over Time .................................................. 127 GLOSSARY OF KEY TERMS........................................................................ 129 APPENDICES ................................................................................................137 Appendix I: Waiver Form Proposed in Preparation for the Terre Haute Experiments ............................................................................................. 138 Appendix II: Chancroid Experiment Report Excerpt ...................................141 Appendix III: Investigation Methods ..........................................................142 Research in Guatemala ............................................................................146 Advisors to the Investigation .....................................................................146 Targeted Interviews .................................................................................148 Staff Delegation to Guatemala ................................................................148 Translation ............................................................................................148 Appendix IV: Subject Database Methods ..................................................... 149 Creation of Subject Database ...................................................................149 Subject Database Quality Control ............................................................ 151 Limitations ............................................................................................ 153 Figures 6, 7, and 8..................................................................................154 Appendix V: Suggestions for Further Reading ............................................. 155 ENDNOTES .................................................................................................. 159 INDEX ......................................................................................................... 203 iv Presidential Commission for the Study of Bioethical Issues President Barack Obama The White House 1600 Pennsylvania Avenue, NW Washington, DC 20500 Dear Mr. President: On behalf of the Presidential Commission for the Study of Bioethical Issues, we present to you this report, “Ethically Impossible”: STD Research in Guatemala from 1946 to 1948. In response to your request of November 24, 2010, the Commission oversaw a thorough fact-finding investigation into the specifics of the U.S. Public Health Service-led studies in Guatemala involving the intentional exposure and infection of vulnerable populations. Following a nine-month intensive investigation, the Commission has concluded that the Guatemala experiments involved gross violations of ethics as judged against both the standards of today and the researchers’ own understanding of applicable contemporaneous practices. It is the Commission’s firm belief that many of the actions undertaken in Guatemala were especially egregious moral wrongs because many of the individuals involved held positions of public institutional responsibility. The best thing we can do as a country when faced with a dark chapter
Recommended publications
  • Pre-Antibiotic Therapy of Syphilis Charles T
    University of Kentucky UKnowledge Microbiology, Immunology, and Molecular Microbiology, Immunology, and Molecular Genetics Faculty Publications Genetics 2016 Pre-Antibiotic Therapy of Syphilis Charles T. Ambrose University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/microbio_facpub Part of the Medical Immunology Commons Repository Citation Ambrose, Charles T., "Pre-Antibiotic Therapy of Syphilis" (2016). Microbiology, Immunology, and Molecular Genetics Faculty Publications. 83. https://uknowledge.uky.edu/microbio_facpub/83 This Article is brought to you for free and open access by the Microbiology, Immunology, and Molecular Genetics at UKnowledge. It has been accepted for inclusion in Microbiology, Immunology, and Molecular Genetics Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Pre-Antibiotic Therapy of Syphilis Notes/Citation Information Published in NESSA Journal of Infectious Diseases and Immunology, v. 1, issue 1, p. 1-20. © 2016 C.T. Ambrose This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This article is available at UKnowledge: https://uknowledge.uky.edu/microbio_facpub/83 Journal of Infectious Diseases and Immunology Volume 1| Issue 1 Review Article Open Access PRE-ANTIBIOTICTHERAPY OF SYPHILIS C.T. Ambrose, M.D1* 1Department of Microbiology, College of Medicine, University of Kentucky *Corresponding author: C.T. Ambrose, M.D, College of Medicine, University of Kentucky Department of Microbiology, E-mail: [email protected] Citation: C.T.
    [Show full text]
  • Informed Consent and Shared Decision Making in EBM
    3 Informed Consent and shared decision making in EBM 3.1 ‘Informed consent’ in regular medical practice ‘Consent’ as it is understood in the medical context has to be asked from the pa- tient and is the explicit agreement to waive a right to certain rules and norms which are normally expected in the treatment of other people and of ourselves as patients. Every surgical procedure would, without consent from the patient, be legally un- derstood as assault and battery and the physician could be prosecuted for perform- ing it. ‘Informed consent’ therefore in its most simple form means that the patient has received a good explanation about a medical procedure, understands what is happening to him or her and then can make an informed choice to accept or refuse, in the latter case the so called ‘informed refusal.167 In order to give ‘informed con- sent the patient has to be capable of understanding the information given by the physician. He or she must be competent to decide and to give consent voluntarily without being coerced by any means into giving consent.168 ‘Autonomy’ of the patient, hereby equated with ‘person’ plays the overarching role in ‘informed con- sent.’ A competent person who exercises autonomy will have the final say about their own life. ‘Autonomy’ itself is a contested term in the philosophy of science and interpretations therefore vary. According to Dworkin, “Liberty (positive or negative) ... dignity, integrity, individuality, independence, responsibility and self knowledge ... self assertion ... critical reflection ... freedom from obligation ... ab- sence of external causation ... and knowledge of one’s own interests.”169 all fall under the definition of autonomy.
    [Show full text]
  • Presentation Abstracts
    Eighth Annual Western Michigan University Medical Humanities Conference Conference Abstracts Hosted by the WMU Medical Humanities Workgroup and the Program in Medical Ethics, Humanities, and Law, Western Michigan University Homer Stryker M.D. School of Medicine September 13-14, 2018 Our Sponsors: Western Michigan University Homer Stryker M.D. School of Medicine, WMU Center for the Study of Ethics in Society, WMU Department of Philosophy Ethics After Error: Malpractice, Mistrust, and the Limits of Medical Moral Repair Ben Almassi, PhD Division of Arts & Letters Governors State University Abstract: One limitation of medical ethics modelled on ideal moral theory is its relative silence on the aftermath of medical error – that is, not just on the recognition and avoidance of injustice, wrongdoing, or other such failures of medical ethics, but how to respond given medical injustice or wrongdoing. Ideally, we would never do each other wrong; but given that inevitably we do, as fallible and imperfect agents we require non-ideal ethical guidance. For such non-ideal moral contexts, I suggest, Margaret Walker’s account of moral repair and reparative justice presents powerful hermeneutical and practical tools toward understanding and enacting what is needed to restore moral relationships and moral standing in the aftermath of injustice or wrongdoing, tools that might be usefully extended to medical ethics and error specifically. Where retributive justice aims to make injured parties whole and retributive justice aims to mete out punishment, reparative justice “involves the restoration or reconstruction of confidence, trust, and hope in the reality of shared moral standards and of our reliability in meeting and enforcing them.” Medical moral repair is not without its challenges, however, in both theory and practice: standard ways of holding medical professionals and institutions responsible for medical error and malpractice function retributively and/or restitutively, either giving benign inattention to patient-practitioner relational repair or impeding it.
    [Show full text]
  • Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic
    ARTICLE https://doi.org/10.1038/s42003-019-0365-y OPEN Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic Venkadesh Sarkarai Nadar1,7, Jian Chen1,7, Dharmendra S. Dheeman 1,6,7, Adriana Emilce Galván1,2, 1234567890():,; Kunie Yoshinaga-Sakurai1, Palani Kandavelu3, Banumathi Sankaran4, Masato Kuramata5, Satoru Ishikawa5, Barry P. Rosen1 & Masafumi Yoshinaga1 The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich’s salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits gluta- mine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the per- vasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors. 1 Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA. 2 Planta Piloto de Procesos Industriales Microbiológicos (PROIMI-CONICET), Tucumán T4001MVB, Argentina. 3 SER-CAT and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
    [Show full text]
  • Tuskegee and the Health of Black Men
    Tuskegee and the Health of Black Men Marcella Alsan and Marianne Wanamaker April 2016 PRELIMINARY. COMMENTS WELCOME. Abstract JEL Codes: I25, O15 For forty years, the Tuskegee Study of Untreated Syphilis in the Negro Male passively monitored hundreds of adult black males with syphilis despite the availability of effective treatment. The study’s methods have become synonymous with exploitation and mistreatment by the medical community. We find that the historical disclosure of the study in 1972 is correlated with in- creases in medical mistrust and mortality and decreases in outpatient physician interactions for black men. Blacks possessing prior experience with the medical community, including veterans and women, appear to have been less affected by the disclosure. Our findings relate to a broader literature on how be- liefs are formed and the importance of trust for economic exchanges involving asymmetric information. We are grateful to William Collins, Joe Ferrie, Nathan Nunn, John Parman, Achyuta Adhvaryu, Arun Chandrasekhar, Martha Bailey, Rebecca Diamond, Claudia Goldin, Melanie Morten, Mark Duggan, Mark Cullen, Melissa Dell, Nancy Qian, Ran Abramitzky, Pascaline Dupas, Rema Hanna, Grant Miller and participants at NBER DAE, University of Tennessee, Vander- bilt Health Policy, Carnegie Mellon Applied Microeconomics, University of Copenhagen Economics, University of Pennsylvania Health Policy, ASSA 2016 Berkeley Population Center, University of Chicago Harris and Stanford Health Policy for constructive comments. We thank the CDC for providing access and to the administrators at the Atlanta and Stanford Census Research Data Centers for their help in navigating the restricted data. We thank Michael Sinkinson, Martha Bailey, Andrew Goodman-Bacon and Walker Hanlon for sharing data and methods.
    [Show full text]
  • United States Court of Appeals for the Ninth Circuit
    Case: 13-36217, 03/14/2016, ID: 9899915, DktEntry: 34-1, Page 1 of 33 FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT GEORGE O. MITCHELL, No. 13-36217 Plaintiff-Appellant, DC No. v. 3:12 cv-05403 BHS STATE OF WASHINGTON; KELLY CUNNINGHAM, SCC Superintendent; DR. THOMAS BELL, OPINION Defendants-Appellees. Appeal from the United States District Court for the Western District of Washington Benjamin H. Settle, District Judge, Presiding Argued and Submitted April 6, 2015—Pasadena, California Filed March 14, 2016 Before: Dorothy W. Nelson, A. Wallace Tashima, and Richard R. Clifton, Circuit Judges. Opinion by Judge Tashima; Concurrence by Judge Clifton Case: 13-36217, 03/14/2016, ID: 9899915, DktEntry: 34-1, Page 2 of 33 2 MITCHELL V. STATE OF WASHINGTON SUMMARY* Prisoner Civil Rights The panel affirmed the district court’s summary judgment in an action brought pursuant to 42 U.S.C. § 1983 in which plaintiff, who is civilly committed as a sexually violent predator, alleged that defendants’ refusal to treat his Hepatitis C with interferon and ribavirin violated his right to reasonable medical care and that the consideration of race in the denial of this treatment violated the Equal Protection Clause. The panel first held the district court erred by finding that the damages claims against the state defendants were barred by the Eleventh Amendment. The panel held that even though plaintiff testified in his deposition that he was suing defendants only in their official capacities, his amended complaint clearly stated that he was suing defendants in both their official and personal capacities for damages and injunctive relief and the record demonstrated that plaintiff, acting pro se, did not understand the legal significance of bringing claims against defendants in their official versus personal capacities.
    [Show full text]
  • Tuskegee Mixer Materials
    Tuskegee Syphilis Study Mixer By Gretchen Kraig-Turner (with additions and revisions by Linda Christensen) Questions: 1. Find someone who supported the study. Who is it? Why did this person support the study? 2. Find someone who was hurt by the Tuskegee Study. Who is it? How was this person hurt? 3. Find someone who took action about the Tuskegee Study. Who is it? What did the person do? 4. Find someone who benefited from the Tuskegee Study. Who is it? How did this person benefit? 5. Find a doctor who was connected to the Tuskegee Study. Who is it? What was his connection to the study? 6. Find someone who was troubled by the Tuskegee Study. Who is it? What troubled this person? 7. Find someone who had to make a choice about their role in the study. Who was it? What choice did the person have to make? Jean Heller: After receiving a tip from whistleblower Peter Buxtun, who worked as an interviewer for the Public Health Service, Associated Press asked me to investigate Buxtun’s claims about an unethical medical study focused on African American men with syphilis. Although I wrote the story that eventually stopped the study, Peter Buxtun was the one who uncovered the story and investigated what he believed was an immoral study. On July 25, 1972, the Washington Evening Star newspaper ran my article on its front page: "Syphilis Patients Died Untreated." I wrote: For 40 years, the U.S. Public Health Service has conducted a study in which human guinea pigs, not given proper treatment, have died of syphilis and its side effects.
    [Show full text]
  • Common Read the Immortal Life of Henrietta Lacks Our Common Read
    Common Read The Immortal Life of Henrietta Lacks Our common read book has inter-disciplinary value/relevance, covering social and biological sciences as well as humanities and education including scientific/medical ethics, nursing, biology, genetics, psychology, sociology, communication, business, criminal justice, history, deaf studies and social justice. Below are chapter summaries that focus on the above disciplines to give respective faculty ideas about how the book can be used for their courses. Part One: Life 1. The Exam….1951: A medical visit at Johns Hopkins, Baltimore, the “northern most Southern city.” Although Johns Hopkins is established as an indigent hospital, Jim Crow era policies/ideologies are pervasive in the care/treatment of black patients. 2. Clover…1920-1942: Birthplace of Henrietta and several of the Lacks family members, including Day, Henrietta’s cousin, husband, and father of her children. A “day in the life” snapshot of life and work in this rural agricultural small town with distinct social/economic divisions across race and socioeconomic status. 3. Diagnosis and Treatment…1951: Henrietta’s diagnosis of cervical carcinomas with a history/statistical profile of diagnostic techniques and prevailing treatment regime of the time. Henrietta’s statement of consent to operative procedures is given along with removal of cancerous tissue and subsequent radium insertion into her cervix. 4. The Birth of HeLa…1951: In depth discussion of the Johns Hopkins lab including the development of an appropriate medium to grow cells. HeLa cells, the first immortal line, are born in this meticulously sterilized lab by the Geys. 5. “Blackness Be Spreadin All Inside”…1951: A look back at the lively, fun loving youthful Henrietta compared to some of the heartache of the birth of Henrietta’s second daughter, Elsie, who was born “special” (epileptic, deaf, and unable to speak).
    [Show full text]
  • Of Rabbits and Men: the Tale of Paul Ehrlich in Our Modern World Of
    Of Rabbits and Men: The Tale of Paul Ehrlich In our modern world of chemotherapy, antibiotics and antivirals, it might come as a surprise to find that the origin of all these treatments can be traced back to rabbits; the cute and fluffy kind. To understand why, we need to go all the way back to 1882 Berlin. A talented, if aimless, young German doctor, Paul Ehrlich, had just met the great microbiologist Robert Koch. Koch was giving a lecture in which he identified the pathogen responsible for tuberculosis. Ehrlich was instantly fascinated by Koch and microbiology. Unknown to himself, he had just taken the first step on a path that would help change the way disease is tackled forever1. The late 1800’s were a time of dynamic change in the sciences. Charles Darwin had proposed his Theory of Natural Selection and Thomas Edison had given us the light bulb. Amongst the many fashionable topics of the time, some biologists were fascinated by dyes; specifically the staining of living tissue. Spending all day bent over a microscope looking at the pretty colours might not seem like worthwhile science by modern standards, but these dyes had interesting properties. Dyes displayed a high level of specificity; they would only stain certain structures and pass through others. Ehrlich noticed this and soon started to think of applications for these properties. These were times when catching a chill could kill. Many well-known individuals of the time were killed in their prime due to infectious disease. Emily Brontë died from tuberculosis2, René Descartes from pneumonia3 and Pyotr Tchaikovsky died from cholera4.
    [Show full text]
  • Medical Ethics Christopher Newport University, Spring 2020
    Medical Ethics Christopher Newport University, Spring 2020 Meeting Info Dr. Chris Tweedt Philosophy 384, Sec. 1 202 McMurran Hall TR 7:30{8:45 pm [email protected] 357 McMurran Hall Office Hours Tuesday & Thursday 2{4 pm Textbook Bioethics: Principles, Issues, and Cases, 3rd ed. by Lewis Vaughn. Outcomes The purpose of this class is to help you 1. clearly and informedly think through ethical decisions, 2. gain an understanding of the arguments and viewpoints relevant to central medical ethics debates 3. learn to discuss polarizing issues in a charitable and respectful manner, especially in the presence of strong disagreement, and 4. develop the ability to charitably and accurately interpret, summarize, and critique philosophical arguments in the context of medical ethics. Overview Medical decisions have consequences|health-related consequences, financial conse- quences, legal consequences, and, most relevant to this course, ethical consequences. When you enter the medical field, you will be faced with difficult ethical decisions. In this course, you will learn how to make these decisions and make them well. The topics of this course are focused on issues that arise in health care professionals real- world practice. This course will present a variety of views on each topic in order to help students understand and articulate their reasons for their positions. The course is divided into three sections. 1. First, we will develop a framework for making ethical decisions. We will address these questions: Why do we treat people, and when do we know when to stop? Which principles should guide our interaction with patients and provision of treat- ment? How should we make decisions when our moral principles conflict? How do we make decisions that we know have a bad effect? How should we deal with mistakes weve made? 2.
    [Show full text]
  • UNIVERSITY of CALIFORNIA the Role of United States Public Health Service in the Control of Syphilis During the Early 20Th Centu
    UNIVERSITY OF CALIFORNIA Los Angeles The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Public Health by George Sarka 2013 ABSTRACT OF THE DISSERTATION The Role of United States Public Health Service in the Control of Syphilis during the Early 20th Century by George Sarka Doctor of Public Health University of California, Los Angeles, 2013 Professor Paul Torrens, Chair Statement of the Problem: To historians, the word syphilis usually evokes images of a bygone era where lapses in moral turpitude led to venereal disease and its eventual sequelae of medical and moral stigmata. It is considered by many, a disease of the past and simply another point of interest in the timeline of medical, military or public health history. However, the relationship of syphilis to the United States Public Health Service is more than just a fleeting moment in time. In fact, the control of syphilis in the United States during the early 20th century remains relatively unknown to most individuals including historians, medical professionals and public health specialists. This dissertation will explore following question: What was the role of the United States Public Health Service in the control of syphilis during the first half of the 20th century? This era was a fertile period to study the control of syphilis due to a plethora of factors including the following: epidemic proportions in the U.S. population and military with syphilis; the ii emergence of tools to define, recognize and treat syphilis; the occurrence of two world wars with a rise in the incidence and prevalence of syphilis, the economic ramifications of the disease; and the emergence of the U.S.
    [Show full text]
  • Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on Its Origins
    History Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on its Origins John Frith, RFD Introduction well as other factors such as education, prophylaxis, training of health personnel and adequate and rapid “If I were asked which is the most access to treatment. destructive of all diseases I should unhesitatingly reply, it is that which Up until the early 20th century it was believed that for some years has been raging with syphilis had been brought from America and the New impunity ... What contagion does World to the Old World by Christopher Columbus in thus invade the whole body, so much 1493. In 1934 a new hypothesis was put forward, resist medical art, becomes inoculated that syphilis had previously existed in the Old World so readily, and so cruelly tortures the before Columbus. I In the 1980’s palaeopathological patient ?” Desiderius Erasmus, 1520.1 studies found possible evidence that supported this hypothesis and that syphilis was an old treponeal In 1495 an epidemic of a new and terrible disease broke disease which in the late 15th century had suddenly out among the soldiers of Charles VIII of France when evolved to become different and more virulent. Some he invaded Naples in the first of the Italian Wars, and recent studies however have indicated that this is not its subsequent impact on the peoples of Europe was the case and it still may be a new epidemic venereal devastating – this was syphilis, or grande verole, the disease introduced by Columbus from America. “great pox”. Although it didn’t have the horrendous mortality of the bubonic plague, its symptoms were The first epidemic of the ‘Disease of Naples’ or the painful and repulsive – the appearance of genital ‘French disease’ in Naples 1495 sores, followed by foul abscesses and ulcers over the rest of the body and severe pains.
    [Show full text]